Central Garden (CENT) Q3 EPS Jumps 18%

Central Garden & Pet (CENT) reported mixed Q3 FY25 results, with non-GAAP EPS of $1.56 exceeding analyst estimates by 9.1% due to significant margin improvement, including a 280 basis point increase in GAAP gross margin driven by operational efficiencies. However, GAAP revenue of $961 million missed forecasts by 3.1%, as both its Pet and Garden segments experienced declining net sales amid demand headwinds and specific segment challenges. Despite these top-line pressures, management reaffirmed its full-year FY2025 non-GAAP EPS guidance of approximately $2.60, signaling confidence in ongoing cost management and productivity initiatives, while continuing share repurchases.

Analysis

Central Garden & Pet (CENT) delivered a mixed fiscal third quarter for 2025, characterized by strong bottom-line execution that offset persistent top-line pressures. The company exceeded non-GAAP EPS estimates by 9.1%, reporting $1.56 against a $1.43 consensus, driven by a significant 280 basis point expansion in GAAP gross margin. This margin improvement, a direct result of the firm's 'Cost and Simplicity' program, underscores successful operational efficiency efforts. However, this profitability was achieved amidst a notable revenue shortfall, with GAAP net sales of $961 million falling 3.1% below expectations and 3.5% year-over-year. Both the Pet and Garden segments experienced sales declines, with the Pet segment's 3% drop attributed to assortment rationalization and softer demand, leading to a lower adjusted EBITDA. The Garden segment's 4% sales decrease was blamed on lost product lines and unfavorable weather, but it showcased impressive operational leverage as its GAAP operating income grew 33%. Management's reaffirmation of its full-year non-GAAP EPS guidance of approximately $2.60, coupled with $55 million in share repurchases, signals confidence in its cost control strategy, but also highlights a dependency on margin defense as revenue remains a key concern.

Key Decisions for Investors

• Investors should weigh the company's proven ability to expand margins and protect earnings against the clear demand headwinds and declining sales in both its core segments.
• Monitor future revenue trends closely, as the reaffirmed EPS guidance appears heavily reliant on continued cost efficiencies rather than top-line growth.
• Consider the explicit risk highlighted by management regarding potential credit issues with brick-and-mortar pet specialty retailers, which could impact future results.
• The ongoing share repurchase program provides support for per-share earnings, but a sustained recovery in sales is likely necessary to justify a higher valuation.